Accounts Payable and Accrued Liabilities

9 Months Ended

Sep. 30, 2024

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities

8. Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consist of the following (in thousands):

	As of
	September 30, 2024		December 31, 2023
Accounts payable and other accrued operating expenses	$	64,950	$	65,393
Accrued clinical trial expenses	19,456		23,711
Accrued professional fees	19,627		13,885
Accrued technical operation expenses	8,953		9,187
Accrued compensation and employee related costs	55,698		48,933
Accrued royalty and milestones payable	6,639		5,674
Accrued interest payable	1,437		2,175
Revenue Interest Payments payable	3,723		3,347
Accrued sales allowances and related costs	14,458		10,937
Accrued France ATU reimbursement payable	19,117		14,685
Deferred and contingent consideration	26,100		6,700
Other accrued liabilities	8,526		10,360
	$	248,684	$	214,987